top of page

Just Launched: A-la-carte marketing services starting at $200/month

Prime Path MedtechTM Inc.

Search

Earnings

As the first quarter earnings season begins, pharmaceutical executives are grappling with multiple sources of market instability, including the looming threat of U.S. tariffs on drugs and significant disruptions within federal health agencies.

As the first quarter earnings season begins, pharmaceutical executives are grappling with multiple sources of market instability, including the looming threat of U.S. tariffs on drugs and significant disruptions within federal health agencies.

Pharma bosses face down investor angst on tariffs, HHS chaos

As the first quarter earnings season begins, pharmaceutical executives are grappling with multiple sources of market instability, including the looming threat of U.S. tariffs on drugs and significant disruptions within federal health agencies.

Madeleine DeSpirito

Apr 131 min read

3 views

0 comments

bottom of page